Humanized ALK Antibody-Drug Shows Cancer-Fighting Promise
In a groundbreaking advance toward precision oncology, researchers have unveiled a novel antibody-drug conjugate (ADC) specifically engineered to target anaplastic ...
In a groundbreaking advance toward precision oncology, researchers have unveiled a novel antibody-drug conjugate (ADC) specifically engineered to target anaplastic ...
Huntsman Cancer Institute at the University of Utah has announced a significant advancement in its approach to cancer treatment and ...
In the complex and challenging landscape of cancer diagnosis, determining the tissue of origin for tumors is a critical step ...
In a groundbreaking advance that promises to transform the landscape of precision oncology, researchers have unveiled an unprecedented multimodal dataset ...
In the relentless pursuit of precision oncology, researchers at Insilico Medicine have unveiled a groundbreaking strategy to develop highly selective ...
In a breakthrough study poised to reshape therapeutic strategies for unresectable hepatocellular carcinoma (uHCC), researchers have identified distinct patterns in ...
A groundbreaking investigation led by the National Cancer Centre Singapore (NCCS) has fundamentally reshaped our understanding of the tumor microenvironment's ...
In a groundbreaking alliance poised to redefine the landscape of cancer treatment, OCCAM Immune—a pioneering initiative under the Icahn School ...
Breast cancer remains the most widespread malignancy affecting women globally, representing a critical challenge for modern oncology and medical research. ...
In the rapidly evolving field of oncology, clinical decision-making remains an intricate and daunting task, demanding deep analysis of multifaceted ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine